(13-108) Evaluation of Remdesivir 3-Day versus 5-Day Treatment Courses in Hospitalized Patients with COVID-19
Wednesday, December 10, 2025
3:15 PM - 4:15 PM
Location: Bayside A, Level 1
Residency Program: Baylor Scott & White All Saints Medical Center- Fort Worth Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Texas
Co-Author(s): Rishi Pahuja, Hasanthi Vallabhaneni, Elizabeth Berihun
